Latest Articles

Publication Date
Kissei Pharmaceutical’s Promising Phase III Study on Endometriosis Treatment - MSN

Kissei Pharmaceutical’s Promising Phase III Study on Endometriosis Treatment MSN

Published: Oct. 30, 2025, 11:45 a.m.
Hutchmed’s Promising Phase III Study on Advanced Endometrial Cancer Treatment - MSN

Hutchmed’s Promising Phase III Study on Advanced Endometrial Cancer Treatment MSN

Published: Oct. 30, 2025, 10:54 a.m.
'Doctors misdiagnosed me with cancer — they apologized after my hysterectomy' - MSN

'Doctors misdiagnosed me with cancer — they apologized after my hysterectomy' MSN

Published: Oct. 30, 2025, 2:56 a.m.
Clinicopathological Diagnosis and Prognosis of Endometrioid Borderline Ovarian Tumors: Dual Case Reports and Literature Review.

Endometrioid borderline ovarian tumor (EBOT) is rare and frequently misdiagnosed. This study aims to investigate the clinicopathological features, immunohistochemical characteristics, differential diagnosis, therapeutic approaches and disease prognosis, thereby establishing a …

Published: Oct. 30, 2025, midnight
Integrative microbiome-metabolomics identifies Pseudomonas as a potential pathogenic factor in endometriosis.

Endometriosis (EMS) is a chronic disease characterized by unclear etiology, influenced by various genetic and environmental factors, with no definitive biomarkers available for early screening. Recent studies suggest that the …

Published: Oct. 30, 2025, midnight
Anti-Angiogenic RNAi-Based Treatment of Endometriosis in a Rat Model Using CXCR4-Targeted Peptide Nanoparticles.

Endometriosis is a common gynecological condition that affects fertility in many women of reproductive age worldwide. This multifaceted disease exhibits a pathogenesis characterized by hormonal and immune system dysregulations, alongside …

Published: Oct. 30, 2025, midnight
Sad reason Bindi missed TV appearance - News.com.au

Sad reason Bindi missed TV appearance News.com.au

Published: Oct. 29, 2025, 2:13 p.m.
Reframing Endometriosis: Interplay of NETs, Macrophages, and Lymphocytes at the Crossroads of Disease Progression, Infertility, and Malignant Transformation.

Endometriosis (ENDO) is a painful, chronic gynecological disease widely affecting women globally. While traditionally classified as a hormonal disorder, ENDO is now increasingly recognized as a multifaceted immune-mediated syndrome driven …

Published: Oct. 29, 2025, midnight
Finding Answers After Years of Dismissed Pain: One Woman's Endometriosis Journey - NBC Palm Springs

Finding Answers After Years of Dismissed Pain: One Woman's Endometriosis Journey NBC Palm Springs

Published: Oct. 28, 2025, 6:30 p.m.
Navigating Tumour Microenvironment in Endometrial Carcinoma: A Comprehensive Review Integrating Immunohistochemistry, Single-cell RNA-sequencing and Spatial Transcriptomics - Frontiers

Navigating Tumour Microenvironment in Endometrial Carcinoma: A Comprehensive Review Integrating Immunohistochemistry, Single-cell RNA-sequencing and Spatial Transcriptomics Frontiers

Published: Oct. 28, 2025, 4:44 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!